Eppendorfs in a lab

Amiselimod

Amiselimod (formerly known as MT-1303) is a tablet developed for relapsing MS by Mitsubishi Tanabe (MT) Pharma.

Current phase of trial: Phase 2

Type of MS: Relapsing MS

Find out more about amiselimod